课题基金 / 基金详情

项目摘要

项目成果

DAVID KEITH ORREN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): RecQ helicases act to maintain genomic stability by an as yet unknown mechanism. When their function is lost, levels of illegitimate recombination increase significantly. Not surprisingly, the human hereditary RecQ deficiency diseases (Werner, Bloom, and Rothmund-Thomson syndromes, caused by defects in WRN, BLM, and RECQL4, respectively) demonstrate early onset and increased frequency of cancer. Importantly, Werner syndrome also shows accelerated development of many age-related problems. Although these diseases have distinct phenotypes, RecQ family members maintain a high degree of homology within and C terminal to the conserved central helicase domain, suggesting that they may have a common mechanistic function and/or DNA substrate specificity. We refer to this extended sequence conservation as the RecQ expanded core. Their illegitimate recombination phenotypes suggest that RecQ helicases function in recombination or anti-recombination pathways, or possibly in resolution of replication fork blockage. Our laboratory has recently uncovered strand pairing and strand exchange activities in WRN and other RecQ helicases consistent with putative roles in these pathways. We hypothesize that the RecQ expanded core forms a functional unit that encompasses DNA binding and catalytic activities. Further, we propose that the function of the RecQ expanded core is to coordinate DNA binding and unwinding to achieve strand exchange reactions in complex recombination or replication intermediates. This hypothesis fits with the putative roles for RecQ members and current biochemical knowledge regarding these proteins. In this proposal, WRN is used as a model RecQ helicase for 1) characterizing strand exchange activity reflecting putative coordination between strand pairing and unwinding activities, 2) examining DNA binding properties and substrate specificity for replication and recombination intermediates, and 3) generating site-directed mutants that pinpoint the DNA binding, enzymatic, and physiological functions of the RecQ expanded core and its individual domains. Our findings with WRN will be highly relevant to elucidating its DNA metabolic role and specific mechanisms underlying carcinogenesis and certain aging phenotypes. Sequence conservation between RecQ helicases also indicates that our findings will be applicable to the functions of other RecQ helicases (including BLM and RECQL4) and their relationships to human health.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/nar/gkm561
发表时间: 2007
期刊: Nucleic acids research
影响因子: 14.9
作者: [Machwe A, Xiao L, Lloyd RG, Bolt E, Orren DK]
通讯作者: Orren DK
DOI: 10.1074/jbc.m110.105411
发表时间: 2011-02-04
期刊: The Journal of biological chemistry
影响因子: --
作者: [Machwe A, Lozada E, Wold MS, Li GM, Orren DK]
通讯作者: Orren DK
Telomeric dysfunction and the premature aging and cancer-prone disease Werner syn
  • 批准号:
    8101170
  • 项目类别:
  • 资助金额:
    $22.86万
  • 财政年份:
    2008
  • 负责人:
    DAVID KEITH ORREN
  • 依托单位:
Telomeric dysfunction and the premature aging and cancer-prone disease Werner syn
  • 批准号:
    7886766
  • 项目类别:
  • 资助金额:
    $23.79万
  • 财政年份:
    2008
  • 负责人:
    DAVID KEITH ORREN
  • 依托单位:
Telomeric dysfunction and the premature aging and cancer-prone disease Werner syn
  • 批准号:
    7666152
  • 项目类别:
  • 资助金额:
    $24.03万
  • 财政年份:
    2008
  • 负责人:
    DAVID KEITH ORREN
  • 依托单位:
Telomeric dysfunction and the premature aging and cancer-prone disease Werner syn
  • 批准号:
    7527641
  • 项目类别:
  • 资助金额:
    $24.03万
  • 财政年份:
    2008
  • 负责人:
    DAVID KEITH ORREN
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: